End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.58 CNY | -0.92% | +2.26% | -18.29% |
04-29 | Healthcare Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-20 | Biggest cyberattacks in US healthcare sector | RE |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Home Furnishings
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.29% | 678M | - | ||
+6.79% | 9.45B | B | ||
+2.00% | 4.02B | C- | ||
+16.49% | 2.45B | C | ||
+16.75% | 1.97B | - | ||
-3.95% | 1.51B | B- | ||
+45.93% | 1.29B | - | ||
-26.45% | 1.19B | C+ | ||
+14.46% | 1.02B | - | ||
+10.84% | 935M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603313 Stock
- Ratings Healthcare Co.,Ltd.